Liu Jie, Feng Jian, Hu Jian, Chen Juan, Li Fu-Xiang, Lin Ning
Department of Clinical Nutrition, The General Hospital of Western Theater Command, Chengdu, Sichuan, 610083, People's Republic of China.
College of Medicine Southwest Jiaotong University, Chengdu, Sichuan, 610031, People's Republic of China.
J Inflamm Res. 2025 Jul 25;18:9871-9878. doi: 10.2147/JIR.S527506. eCollection 2025.
Sepsis is defined as a severe systemic inflammation, often triggered by an infection, resulting in organ dysfunction and mortality. In recent years, ZBP1 (Z-DNA binding protein 1) has garnered significant attention as a critical immune regulatory factor in the pathogenesis of sepsis. This article aims to comprehensively explore the mechanisms by which ZBP1 operates in sepsis and summarize the relevant research progress. This study will seek to highlight the potential of ZBP1 as a therapeutic target and biomarker in the context of sepsis through an in-depth analysis of its functions in cellular signaling, inflammatory response, and immune response. This review seeks to provide new insights for the clinical management of sepsis.
脓毒症被定义为一种严重的全身性炎症,通常由感染引发,可导致器官功能障碍和死亡。近年来,ZBP1(Z-DNA结合蛋白1)作为脓毒症发病机制中的关键免疫调节因子受到了广泛关注。本文旨在全面探讨ZBP1在脓毒症中发挥作用的机制,并总结相关研究进展。通过深入分析ZBP1在细胞信号传导、炎症反应和免疫反应中的功能,本研究将致力于凸显其作为脓毒症治疗靶点和生物标志物的潜力。本综述旨在为脓毒症的临床管理提供新的见解。